Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
24.87
-0.36 (-1.43%)
May 15, 2026, 4:00 PM EDT - Market closed
PBPH Holdings Information
PBPH is an equity ETF with a total of 56 individual holdings. The top holdings are Eli Lilly and Company stock at 14.03%, Johnson & Johnson at 9.08%, AbbVie at 6.02%, Roche Holding AG at 4.63%, and Novartis AG at 4.60%.
Total Holdings
56
Top 10 Percentage
59.74%
Asset Class
Equity
ETF Category
Health
Assets
760.83M
PE Ratio
19.43
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 14.03% |
| 2 | JNJ | Johnson & Johnson | 9.08% |
| 3 | ABBV | AbbVie Inc. | 6.02% |
| 4 | SWX: ROP | Roche Holding AG | 4.63% |
| 5 | SWX: NOVN | Novartis AG | 4.60% |
| 6 | MRK | Merck & Co., Inc. | 4.58% |
| 7 | LON: AZN | AstraZeneca PLC | 4.45% |
| 8 | GILD | Gilead Sciences, Inc. | 4.29% |
| 9 | AMGN | Amgen Inc. | 4.18% |
| 10 | CPH: NOVO.B | Novo Nordisk A/S | 3.88% |
| 11 | PFE | Pfizer Inc. | 3.83% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.99% |
| 13 | BMY | Bristol-Myers Squibb Company | 2.98% |
| 14 | LON: GSK | GSK plc | 2.48% |
| 15 | EPA: SAN | Sanofi | 2.41% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.91% |
| 17 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.31% |
| 18 | EBR: ARGX | argenx SE | 1.28% |
| 19 | ETR: BAYN | Bayer Aktiengesellschaft | 1.15% |
| 20 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 1.08% |
| 21 | ASX: CSL | CSL Limited | 1.03% |
| 22 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.00% |
| 23 | SWX: SDZ | Sandoz Group AG | 0.91% |
| 24 | EBR: UCB | UCB SA | 0.87% |
| 25 | ZTS | Zoetis Inc. | 0.81% |
As of May 14, 2026